文献速递湿疹皮炎与荨麻疹

慢性荨麻疹患者精神疾病风险更高:一项基于人群的研究

Patients with chronic urticaria have a higher risk of psychiatric disorders: a population-based study.
PubMed 文献 · Br J Dermatol · 2019-09-18

BACKGROUND: The prevalence of psychiatric comorbidities in patients with chronic urticaria (CU) in a national population is largely unknown. OBJECTIVES: To investigate the prevalence of psychiatric disorders and psychiatric medication use in patients with CU in Taiwan.…

要点

  • CU患者精神疾病患病率及精神科药物使用率均高于对照人群。
  • CU管理应包含心理健康评估与干预。

核心结论

  • 慢性荨麻疹患者精神疾病患病率及精神科药物处方率高于对照组,且风险随病情严重程度增加。

关键数值与推荐

  • 精神疾病定义为具有指定精神疾病主要或次要诊断的三次门诊就诊。
  • 精神科药物使用定义为2010年或2011年至少四次门诊就诊并处方抗焦虑药、抗抑郁药或安眠药。

临床怎么用

  • 在慢性荨麻疹管理中应重视心理健康评估与处理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The prevalence of psychiatric comorbidities in patients with chronic urticaria (CU) in a national population is largely unknown. OBJECTIVES: To investigate the prevalence of psychiatric disorders and psychiatric medication use in patients with CU in Taiwan. METHODS: Data were sourced from Taiwan's National Health Insurance Research Database for 2011. Patients who had a primary/secondary International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis code of 708·1, 708·8 or 708·9 during 2011 with at least two outpatient visits and an antihistamine prescription were identified as CU cases. Patients with CU were classified into three disease severity groups according to their medication types. Psychiatric disorders were identified by patients having three outpatient visits with a primary or secondary diagnosis of a given psychiatric disease. Psychiatric medication use was defined by having at least four outpatient visits with prescriptions for anxiolytics, antidepressants or sleeping pills in 2010 or 2011. RESULTS: Of the 167 132 patients with CU, 82·5% had mild CU, 17·0% had moderate CU and 0·4% had severe CU. Patients with CU had a higher prevalence of psychiatric disorders and psychiatric medication prescription than control groups. The relative risk (RR) of psychiatric disorders was 1·43 for patients with mild, 1·50 for patients with moderate and 2·32 for patients with severe CU vs. the controls (P < 0·001). For psychiatric medication prescription, the RRs were 1·95, 2·70 and 2·09, respectively, vs. controls (P < 0·001). CONCLUSIONS: Patients with CU had a higher prevalence and risk of psychiatric disorders and psychiatric medication prescription than control groups. What's already known about this topic? Previous studies have shown a high prevalence of psychiatric comorbidities in patients with chronic urticaria (CU), with rates ranging from 35% to 60%. Anxiety, depression and somatoform disorders have been reported as the most prevalent mental disorders in patients with CU. What does this study add? Patients with CU had a higher prevalence of psychiatric disorders and psychiatric medication use than control groups in the general population. The relative risk (RR) of psychiatric disorders was 1·43 for those with mild CU, 1·50 for those with moderate CU and 2·32 for those with severe CU vs. controls. The RR for psychiatric medication use was 1·95 for those with mild CU, 2·70 for those with moderate CU and 2·09 for those with severe CU vs. controls. Mental health evaluations and management are important elements in CU management.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Chu CY, Cho YT, Jiang JH, et al. Patients with chronic urticaria have a higher risk of psychiatric disorders: a population-based study. Br J Dermatol. 2019. PMID: 31220338. doi:10.1111/bjd.18240

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。